Hepatitis B Trial, Recruiting NCT06874127 Sponsor: Beijing Friendship Hospital Condition: Hepatitis B
Back to Hepatitis B

Hepatitis B Trial, Recruiting

NCT06874127
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You had a liver tissue sample (biopsy) taken at least 1 year after completing antiviral treatment
  • You had a liver biopsy, a liver stiffness test, or a specific blood test (called APRI, which measures liver health using two markers in your blood) done before starting antiviral treatment

Who may not be able to join:

  • You had serious liver complications (such as fluid build-up in the abdomen, confusion caused by liver problems, bleeding in the food pipe, kidney problems related to the liver, or serious infections) before your liver biopsy
  • You had liver cancer or a liver transplant before your liver biopsy
  • You have hepatitis C, HIV, liver disease caused by alcohol, an immune system attacking your liver, an inherited liver condition, liver damage from medications, or any other ongoing chronic liver disease
  • A scan of your liver showed signs of a cancerous growth
  • You have another type of cancer that has not been fully treated or cured
  • You have serious problems with your heart, lungs, kidneys, brain, blood, mental health, or other major organs
  • You are currently pregnant or breastfeeding
  • There is any other reason the study team considers you unsuitable for the trial (confirm with trial site)

⚠️ Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 23 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 0086-13810643902

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Beijing Friendship Hospital
Registry
ClinicalTrials.gov
Start date
1 February 2024
Est. completion
1 February 2026

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Diagnostic accuracy of non-invasive model for fibrosis regression

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov